Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT — Stella

Home/Intravenous/Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT

View on ClinicalTrials.gov

Recruiting

Back to Intravenous trials

Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Thailand

Siriraj Stroke Center,Siriraj Hospital, Bangkok

Key details

Phase

Post-approval study

Sponsor

Mahidol University

Enrollment target

~160 participants

Started

August 2022

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.